PRS
PTLA

Pinkerton Retirement Specialists’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Pinkerton Retirement Specialists’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-18
Closed – – 553
2016
Q4 		$0 Hold
18
– – ﹤0.01% 665
2016
Q3 		$0 Hold
18
– – ﹤0.01% 678
2016
Q2 		$0 Buy
+18
New +$444 ﹤0.01% 668

Other funds holding PTLA

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Pinkerton Retirement Specialists's PTLA Position: Q1 2017 in Review

Pinkerton Retirement Specialists sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2017, closing a stake of 18 shares.

Pinkerton Retirement Specialists first reported a position in PTLA in Q2 2016 and held it in 3 quarters. The position peaked at $0 in Q4 2016. 180 funds tracked by Wall St. Rank hold PTLA as of Q1 2017.

  • Pinkerton Retirement Specialists reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
  • Pinkerton Retirement Specialists sold 18 Portola Pharmaceuticals, Inc. shares in Q1 2017.
  • Pinkerton Retirement Specialists first reported a position in Portola Pharmaceuticals, Inc. in Q2 2016 and held it in 3 quarters.
  • Pinkerton Retirement Specialists's Portola Pharmaceuticals, Inc. position peaked at $0 in Q4 2016.
  • 180 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2017.

Based on Pinkerton Retirement Specialists's 13F filing for Q1 2017, filed 15 May 2017.